Mills Ch3 Breast

82

SECTION II : Breast

2. Leung JW. New modalities in breast imaging: digital mammog- raphy, positron emission tomography, and sestamibi scintimam- mography. Radiol Clin North Am 2002;40(3):467–482. 3. Koomen M, Pisano ED, Kuzmiak C, et al. Future directions in breast imaging. J Clin Oncol 2005;23(8):1674–1677. 4. Hylton N. Magnetic resonance imaging of the breast: oppor- tunities to improve breast cancer management. J Clin Oncol 2005;23(8):1678–1684. 5. Rosen PP. Rosen’s Breast Pathology . 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. 6. Tavassoli FA. Normal development and anomalies. In: Tavas- soli FA, ed. Pathlogy of the Breast . 2nd ed. Stamford, CT: Appelton and Lange; 1999:1–25. 7. Osborne MP. Breast anatomy and development. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast . 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010:3–11. 8. McCarty KS, Nath M. Breast. In: Sternberg SS, ed. Histol- ogy for Pathologists . Philadelphia, PA: Lippincott-Raven; 1997: 71–82. 9. Anbazhagan R, Bartek J, Monaghan P, et al. Growth and development of the human infant breast. Am J Anat 1991; 192(4):407–417. 10. Monaghan P, Perusinghe NP, Cowen P, et al. Peripubertal human breast development. Anat Rec 1990;226(4):501–508. 11. Going JJ, Moffat DF. Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol 2004;203(1):538–544. 12. Going JJ, Mohun TJ. Human breast duct anatomy, the ‘sick lobe’ hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat 2006;97(3):285–291. 13. Tot T. The theory of the sick breast lobe and the possible consequences. Int J Surg Pathol 2007;15(4):369–375. 14. Jensen HM. Breast pathology, emphasizing precancerous and cancer-associated lesions. In: Bulbrook RO, Taylor DJ, eds. Commentaries on Research in Breast Disease . Vol. 2. New York: Alan R. Liss; 1981:41–86. 15. Page OL, Anderson TJ. Diagnostic Histopathology of the Breast . Edinburgh: Churchill Livingstone; 1987. 16. Love SM, Barsky SH. Anatomy of the nipple and breast ducts revisited. Cancer 2004;101(9):1947–1957. 17. Rusby JE, Brachtel EF, Michaelson JS, et al. Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications. Breast Cancer Res Treat 2007;106(2): 171–179. 18. Ohtake T, Kimijima I, Fukushima T, et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 2001;91(12):2263–2272. 19. Schnitt SJ, Millis RR, Hanby AM, et al. The Breast . In: Mills SE, ed. Diagnostic Surgical Pathology . 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2004:323–395. 20. Jarasch ED, Nagle RB, Kaufmann M, et al. Differential diag- nosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 1988; 19(3):276–289. 21. Bocker W, Bier B, Freytag G, et al. An immunohistochemi- cal study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions. Virchows Arch A Pathol Anat Histopathol 1992;421(4):315–322.

22. Heatley M, Maxwell P, Whiteside C, et al. Cytokeratin inter- mediate filament expression in benign and malignant breast disease. J Clin Pathol 1995;48(1):26–32. 23. Bocker W, Moll R, Poremba C, et al. Common adult stem cells in the human breast give rise to glandular and myoepi- thelial cell lineages: a new cell biological concept. Lab Invest 2002;82(6):737–746. 24. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004;203(2):661–671. 25. Yaziji H, Gown AM, Sneige N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol 2000;7(2):100–109. 26. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25(8): 1054–1060. 27. Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 2002;15(4):397–405. 28. Yeh IT, Mies C. Application of immunohistochemistry to breast lesions. Arch Pathol Lab Med 2008;132(3):349–358. 29. Bhargava R, Dabbs DJ. Use of immunohistochemistry in diagnosis of breast epithelial lesions. Adv Anat Pathol 2007; 14(2):93–107. 30. Popnikolov NK, Cavone SM, Schultz PM, et al. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells. Mod Pathol 2005;18(12): 1535–1541. 31. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10(16):5367–5674. 32. Going JJ. Normal Breast . In: O’Malley FP, Pinder SE, Goldblum JR, eds. Philadelphia, PA: Churchill, Livingstone, Elsevier; 2006:55–65. 33. Santagata S, Thakkar A, Ergonul A, et al. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Invest 2014;124(2):859–870. 34. Boecker W, Weigel S, Handel W, et al. The normal breast. In: Boecker W, ed. Preneoplasia of the Breast: A New Conceptual Approach to Proliferative Breast Disease . Munich: Elsevier; 2006: 2–27. 35. Cariati M, Purushotham AD. Stem cells and breast cancer. Histopathology 2008;52(1):99–107. 36. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439(7072):84–88. 37. Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker alde- hyde dehydrogenase 1-positive breast cancers are character- ized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 2009;100(6):1062–1068. 38. Zhou L, Jiang Y, Yan T, et al. The prognostic role of cancer stem cells in breast cancer: A meta-analysis of published literatures. Breast Cancer Res Treat 2010;122(3):795–801. 39. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospec- tive identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100(7):3983–3988. 40. Barsky SH, Siegal GP, Jannotta F, et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983;49(2):140–147.